Skip to main content
STAA logo

STAAR Surgical Company

STAANASDAQHealthcareMedical Instruments & Supplies

$25.24Today:- (-)1Y −16.58%

As of Oct 29, 2026 close

Market cap
$1.30B
P/E (TTM)
8073.82
Forward P/E
-
Dividend yield
-
52-week range
$15.59$35.87
Volume (live)
-
Avg. volume (3M)
852.34K

STAAR Surgical Company (STAA) Financial Ratios

For fiscal 2025 (fiscal year ended Jan 2, 2026), STAAR Surgical Company had return on equity of -21.7% (down from -5.2%), debt-to-equity of 0.11 (up from 0.10), a current ratio of 4.55 (down from 5.23) and return on assets of -5.9% (down from -1.6%). A current ratio of 4.55 means current assets exceed current liabilities.

STAAR Surgical Company Financial Ratios Analysis

Valuation, profitability, leverage, and liquidity ratios

Scroll to see more
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Period endingJan 2026Dec 2024Dec 2023Dec 2022Dec 2021Jan 2021
Valuation Ratios
P/E Ratio--71.3658.99157.96617.61
Forward P/E46.8334.6731.2141.4499.97165.04
P/S Ratio4.903.804.728.2318.8622.34
P/B Ratio3.413.003.956.9616.8118.52
Price/Tangible Book3.773.143.967.0016.9418.71
Price/FCF---132.89143.34291.06
Price/OCF-75.84104.3765.5198.85174.31
PEG Ratio0.931.161.041.383.335.50
Enterprise Value Ratios
EV/Revenue4.263.174.257.5918.1121.61
EV/EBITDA--39.3644.22113.15360.79
EV/EBIT--46.1548.72125.55527.51
EV/FCF---122.58137.64281.60
Profitability & Returns
Return on Equity (ROE)-21.70%-5.16%5.91%13.34%12.07%3.31%
Return on Assets (ROA)-5.95%-1.55%4.09%7.24%6.89%1.80%
Return on Invested Capital (ROIC)-22.84%-6.07%10.56%31.31%39.88%9.12%
Return on Capital Employed (ROCE)-11.90%-2.80%7.00%12.10%11.20%3.10%
Leverage & Solvency Ratios
Debt/Equity0.110.100.090.090.120.06
Debt/EBITDA-12.430.890.580.800.84
Debt/FCF---1.761.060.86
Liquidity Ratios
Current Ratio4.555.235.626.035.565.25
Quick Ratio3.534.414.905.375.054.63
Efficiency Ratios
Asset Turnover0.500.630.710.740.760.70
Inventory Turnover1.151.902.352.942.932.56
Yield & Distribution Ratios
Earnings Yield-6.85%-1.69%1.40%1.70%0.63%0.16%
FCF Yield-3.41%-0.64%-0.24%0.75%0.70%0.34%
Buyback Yield-0.90%0.61%-0.09%0.15%-3.13%-2.26%

Source: Company financial statements from annual and quarterly filings. Data as of Jul 3, 2026. Data sources and methodology

Frequently Asked Questions About STAAR Surgical Company Financial Ratios

What is STAAR Surgical Company's return on equity?

STAAR Surgical Company's return on equity (ROE) was -21.7% for fiscal 2025 (period ended Jan 2, 2026). It was -5.2% a year earlier.

What is STAAR Surgical Company's debt-to-equity ratio?

STAAR Surgical Company's debt-to-equity ratio was 0.11 for fiscal 2025 (period ended Jan 2, 2026). It was 0.10 a year earlier.

What is return on equity (ROE)?

Return on equity is net income divided by shareholders' equity. It measures how much profit a company generates from the capital its shareholders have invested. Full definition